This observation hints that the SE‐driven CRC orchestrated by SOX9‐TCF7L2 within these GBC lines might confer to their heightened sensitivity to SE‐targeted transcription inhibition interventions. This evidence concerns the gene TCF7L2 and colorectal carcinoma.